Visits: 5
The new manufacturing site would be able to produce several hundred of million doses of mRNA-based vaccines per year, depending on the type, BioNTech said. Read More Go To Source
Visits: 5
The new manufacturing site would be able to produce several hundred of million doses of mRNA-based vaccines per year, depending on the type, BioNTech said. Read More Go To Source
Copyright © 2020 | Fastinews.com